Nonprofits Urge HHS To Take Over Sarepta's Exondys Patents

Law360 (April 5, 2018, 8:03 PM EDT) -- A group of nonprofits on Thursday urged the U.S. Department of Health and Human Services to take over five patents covering Sarepta Therapeutics Inc.’s controversially approved and expensive muscular dystrophy drug Exondys 51, saying federal funding wasn’t disclosed in the patent applications.

Under the Bayh-Dole Act, inventors are required to disclose when a patent was developed with any government funding, and Knowledge Ecology International has been on a mission to have that enforced. The group has filed multiple petitions targeting patents that cover expensive drugs, hoping to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.